EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H13NO3 |
| Net Charge | 0 |
| Average Mass | 255.273 |
| Monoisotopic Mass | 255.08954 |
| SMILES | O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O |
| InChI | InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19) |
| InChIKey | OZWKMVRBQXNZKK-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | cyclooxygenase 1 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 1. cyclooxygenase 2 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 2. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ketorolac (CHEBI:6129) has part (R)-ketorolac (CHEBI:76227) |
| ketorolac (CHEBI:6129) has part (S)-ketorolac (CHEBI:76228) |
| ketorolac (CHEBI:6129) has role analgesic (CHEBI:35480) |
| ketorolac (CHEBI:6129) has role cyclooxygenase 1 inhibitor (CHEBI:50630) |
| ketorolac (CHEBI:6129) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| ketorolac (CHEBI:6129) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| ketorolac (CHEBI:6129) is a racemate (CHEBI:60911) |
| ketorolac (CHEBI:6129) is conjugate acid of ketorolac(1−) (CHEBI:76229) |
| Incoming Relation(s) |
| ketorolac(1−) (CHEBI:76229) is conjugate base of ketorolac (CHEBI:6129) |
| IUPAC Name |
|---|
| rac-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
| INNs | Source |
|---|---|
| ketorolac | ChemIDplus |
| kétorolac | WHO MedNet |
| ketorolaco | ChemIDplus |
| ketorolacum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid | ChemIDplus |
| rac-ketorolac | ChEBI |
| (±)-ketorolac | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Reaxys:413572 | Reaxys |
| CAS:74103-06-3 | KEGG DRUG |
| CAS:74103-06-3 | ChemIDplus |
| CAS:74103-06-3 | KEGG COMPOUND |
| Citations |
|---|